NCT02155049View on ClinicalTrials.gov

Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues

PHASE3CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Thyroid Associated Ophthalmopathies
Interventions
DRUG

bimatoprost 0.03%

The patients will receive a single daily drop of bimatoprost for six months.

Trial Locations (1)

Unknown

Ophthalmology clinics, Rabin Medical Center, Petah Tikva

All Listed Sponsors
lead

Rabin Medical Center

OTHER

NCT02155049 - Treatment of Soft Tissue Expansion in Inactive Thyroid Eye Disease Patients Using Drops of Prostaglandin Analogues | Biotech Hunter | Biotech Hunter